Upcoming Webinar :Register now for 'ULIP as an investment during economic recovery' powered by Bajaj Allianz

Granules q2 PAT Seen Up 19% YoY To Rs. 72 Cr: Emkay

Net Sales are expected to increase by 13 percent Y-o-Y (up 10.3 percent Q-o-Q) to Rs. 656.4 crore, according to Emkay.

Oct 14, 2019 / 04:09 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Emkay has come out with its second quarter (July-September’ 19) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Granules to report net profit at Rs. 72 crore up 19% year-on-year (down 14% quarter-on-quarter).


Net Sales are expected to increase by 13 percent Y-o-Y (up 10.3 percent Q-o-Q) to Rs. 656.4 crore, according to Emkay.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 31 percent Y-o-Y (up 11 percent Q-o-Q) to Rs. 131.3 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Moneycontrol News

stay updated

Get Daily News on your Browser
Sections